MapLight Therapeutics, Inc. (MPLT) — Financial statements
Income statement, balance sheet, and cash flow for MapLight Therapeutics, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue & Gross Profit | |||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.58↓17.5% | 0.70↑26.1% | 0.56↓3.1% | 0.57 | |
| Gross Profit | -0.58↑17.5% | -0.70↓26.1% | -0.56↑3.1% | -0.57 | |
| Operating Expenses | |||||
| R&D Expenses | 138↑103.1% | 68↑38.1% | 49↑84.9% | 27 | |
| General & Administrative Expenses | 0.00↓100.0% | 14↑89.6% | 8↑85.5% | 4 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 31↑113.1% | 14↑89.6% | 8↑85.5% | 4 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 169↑104.9% | 82↑45.0% | 57↑84.9% | 31 | |
| Total Costs & Expenses | 169↑103.8% | 83↑44.8% | 57↑83.3% | 31 | |
| Operating Results | |||||
| Operating Income | -169↓103.8% | -83↓44.8% | -57↓83.3% | -31 | |
| Depreciation & Amortization | 0.58↓17.5% | 0.70↑26.1% | 0.56↓3.1% | 0.57 | |
| EBITDA | -169↓119.2% | -77↓39.4% | -55↓87.3% | -29 | |
| EBIT | -169↓117.9% | -78↓39.3% | -56↓85.6% | -30 | |
| Interest & Other Income | |||||
| Net Interest Income | 6↑22.5% | 5↑309.8% | 1↑156.2% | 0.43 | |
| Interest Income | 6↑22.5% | 5↑309.8% | 1↑156.2% | 0.43 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -5↓241.1% | -2↓28.0% | -1 | |
| Other Income / Expenses | 8↑47.8% | 5↑241.1% | 2↑28.0% | 1 | |
| Income Before Tax | -161↓107.7% | -78↓39.3% | -56↓85.6% | -30 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | |||||
| Net Income from Continuing Operations | -161↓107.7% | -78↓39.3% | -56↓85.6% | -30 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -161↓107.7% | -78↓39.3% | -56↓85.6% | -30 | |
| Bottom-Line Net Income | -161↓107.7% | -78↓39.3% | -56↓85.6% | -30 | |
| EPS (Basic) | -3.66↓95.7% | -1.87↓39.6% | -1.34↓86.1% | -0.72 | |
| EPS (Diluted) | -3.66↓95.7% | -1.87↓39.6% | -1.34↓86.1% | -0.72 | |
| Weighted Average Shares | 44↑6.3% | 41↑0.0% | 41↑0.0% | 41 | |
| Weighted Average Diluted Shares | 44↑6.3% | 41↑0.0% | 41↑0.0% | 41 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.